Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies Volume II

3,093
Total downloads
11k
Total views and downloads

Articles

REVIEW

Published on 23 Dec 2024

Revolutionizing Ovarian Cancer Therapy by Drug Repositioning for Accelerated and Cost-Effective Treatments

Edgar Yebran Villegas-Vazquez
Francisco Pável Marín-Carrasco
Octavio Daniel Reyes-Hernández
Andrea Baez-Gonzalez
Lilia Patricia Bustamante-Montes
Teresita Padilla-Benavides
Laura Itzel Quintas-Granados
Gabriela Figueroa-González

doi 10.3389/fonc.2024.1514120

BRIEF RESEARCH REPORT

Published on 15 Nov 2024

Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone

Brenna C. McAllister
Nooshin Mesbahi
Esther E. Dodson
Sakinah Abdulsalam
Clifford E. Berkman
Leslie A. Caromile

doi 10.3389/fonc.2024.1504514

493 views

REVIEW

Published on 08 Oct 2024

Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration

William Han Bae
Stefania Maraka
Ahmad Daher

doi 10.3389/fonc.2024.1441460

728 views
1 citation

ORIGINAL RESEARCH

Published on 22 May 2024

Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients

Changye Zou
Renxuan Huang
Tiao Lin
Yaxian Wang
Jian Tu
Liwen Zhang
Bo Wang
Jintao Huang
Zhiqiang Zhao
4 more
Jingnan Shen

Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients

doi 10.3389/fonc.2024.1382276

981 views

MINI REVIEW

Published on 08 May 2024

Drug repositioning in thyroid cancer: from point mutations to gene fusions

David Sánchez-Marín
Macrina Beatriz Silva-Cázares
Manuel González-Del Carmen
Alma D. Campos-Parra

Drug repositioning in thyroid cancer: from point mutations to gene fusions

doi 10.3389/fonc.2024.1407511

879 views

ORIGINAL RESEARCH

Published on 20 Mar 2024

Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4BG13D/PDE6δ complex

Dayan A. Carrión-Estrada
Arturo Aguilar-Rojas
Sara Huerta-Yepez
Mayra Montecillo-Aguado
Martiniano Bello
Arturo Rojo-Domínguez
Elena Arechaga-Ocampo
Paola Briseño-Díaz
Marco Antonio Meraz-Ríos
2 more
Miguel Vargas

Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4BG13D/PDE6δ complex

doi 10.3389/fonc.2024.1341766

1,431 views

ORIGINAL RESEARCH

Published on 16 Feb 2024

National expert consensus on home-administered oncologic therapies in Spain

Eulalia Villegas
María Arruñada
Miguel Ángel Casado
Sonia González
María Estela Moreno-Martínez
María Ángeles Peñuelas
Ana Maria Torres
Yanik Sierra
Miguel Angel Seguí

National expert consensus on home-administered oncologic therapies in Spain

doi 10.3389/fonc.2024.1335344

2,197 views

ORIGINAL RESEARCH

Published on 05 Jan 2024

Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression

Simon Pernot
Mercedes Tomé
Isabel Galeano-Otero
Serge Evrard
Iker Badiola
Frederic Delom
Delphine Fessart
Tarik Smani
Geraldine Siegfried
1 more
Abdel-Majid Khatib

Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression

doi 10.3389/fimmu.2023.1278630

1,942 views

Share on

Frontiers in Oncology

Frontiers in Oncology

Molecular and Cellular Oncology

Participating Journals

Frontiers in Cell and Developmental Biology
- Molecular and Cellular OncologyOffline
- 4.6 impact factor
- 9.7 citescore

Impact

11kTopic views
7,836Article views
3,093Article downloads